health pharma news today obesity drugs glp-1 today Alarming rise in weight loss drug overdoses Market Overview: GLP-1 Agonists and
Description
The results of previous trials are encouraging in terms of multiple positive effects of GLP-1 receptor agonists
Clinical studies consistently demonstrate that semaglutide offers superior results compared to other GLP-1 receptor agonists, such as liraglutide
Lets address the scale
AstraZeneca plc (UK) Established in 1999, AstraZeneca has played an important role in expanding treatment options in type 2 diabetes through its work in GLP-1 and related metabolic pathways
Abu EK, O Ofori A, B Boadi-Kusi S, et al
BMJ 379 , e071380 (2022)
